Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Ewing

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|September 30, 2010
Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor statusKazutoshi Fujita, Charles M Ewing, William B Isaacs, et al.
Journal of Cellular and Molecular Medicine|March 1, 2011
Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblastsMichelle L Jones, Charles M Ewing, William B Isaacsa, et al.
Oncogene|April 20, 2002
In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesisDennis R Chesire, Charles M Ewing, Wesley R Gage, et al.
The Prostate|September 2, 2003
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinomaJun Luo, Thomas A Dunn, Charles M Ewing, et al.
The Journal of Urology|December 11, 2003
Cadherin-6: a new prognostic marker for renal cell carcinomaRoger Paul, Ulrike Necknig, Raymonde Busch, et al.
Cancer Research|April 3, 2004
Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cellsDennis R Chesire, Thomas A Dunn, Charles M Ewing, et al.
The Prostate|November 11, 2009
Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasiaKazutoshi Fujita, Charles M Ewing, Robert H Getzenberg, et al.
The Prostate|December 19, 2018
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancerDorhyun Johng, Gonzalo Torga, Charles M Ewing, et al.
International Journal of Cancer|November 13, 2008
Endoglin (CD105) as a urinary and serum marker of prostate cancerKazutoshi Fujita, Charles M Ewing, David Y S Chan, et al.
Cancer Research|November 13, 2003
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancerShan Zha, Sacha Ferdinandusse, Simone Denis, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|September 30, 2010
Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor statusKazutoshi Fujita, Charles M Ewing, William B Isaacs, et al.
Journal of Cellular and Molecular Medicine|March 1, 2011
Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblastsMichelle L Jones, Charles M Ewing, William B Isaacsa, et al.
Oncogene|April 20, 2002
In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesisDennis R Chesire, Charles M Ewing, Wesley R Gage, et al.
The Prostate|September 2, 2003
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinomaJun Luo, Thomas A Dunn, Charles M Ewing, et al.
The Journal of Urology|December 11, 2003
Cadherin-6: a new prognostic marker for renal cell carcinomaRoger Paul, Ulrike Necknig, Raymonde Busch, et al.
Cancer Research|April 3, 2004
Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cellsDennis R Chesire, Thomas A Dunn, Charles M Ewing, et al.
The Prostate|November 11, 2009
Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasiaKazutoshi Fujita, Charles M Ewing, Robert H Getzenberg, et al.
The Prostate|December 19, 2018
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancerDorhyun Johng, Gonzalo Torga, Charles M Ewing, et al.
International Journal of Cancer|November 13, 2008
Endoglin (CD105) as a urinary and serum marker of prostate cancerKazutoshi Fujita, Charles M Ewing, David Y S Chan, et al.
Cancer Research|November 13, 2003
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancerShan Zha, Sacha Ferdinandusse, Simone Denis, et al.
Pageof 4